Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure

By Mayer-Sonnenfeld Tehila   Har-Noy Michael   Lillehei Kevin O.   Graner Michael W.  

International Journal of Hyperthermia, Vol. 29, Iss. 6, 2013-09 ,pp. : 520-527

Informa Healthcare

Access to resources Recommend Favorite

Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine

By Epple Laura M.  

International Journal of Hyperthermia, Vol. 29, Iss. 5, 2013-08 ,pp. : 390-398

Informa Healthcare

Access to resources Recommend Favorite

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

By Todryk Stephen   Eaton Jonathan   Birchall Lindsay   Greenhalgh Rebecca   Soars Diane   Dalgleish Angus   Melcher Alan   Pandha Hardev  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 323-330

Springer Publishing Company

Access to resources Recommend Favorite

Altered Glycosylation of Proteins in Cancer: What Is the Potential for New Anti-Tumour Strategies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 1, 2008-01 ,pp. : 2-21

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour-derived, Endocrine, Exogenous and Therapeutic Factors Differentially Modulate Cytokine Secretion in Whole Blood Cell Culture

By Fischer J.R.   Schindel M.   Lahm H.   Drings P.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1661-1667

Elsevier

Access to resources Recommend Favorite